Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sodium-dependent noradrenaline transporter (NET) is a membrane protein responsible for the reuptake of extracellular norepinephrine (noradrenaline) and, to a lesser extent, dopamine from the synaptic cleft back into presynaptic neurons. This process is essential for regulating neurotransmitter levels in the central and peripheral nervous systems. Dysfunction or altered expression has been linked to psychiatric disorders such as ADHD and depression; it is also implicated in cardiovascular diseases. NET is targeted by several classes of drugs, including tricyclic antidepressants and SNRIs.
Inhibition of norepinephrine and/or dopamine reuptake from the synaptic cleft.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent Noradrenaline Transporter (NET).